IgG Stabilization via Mannitol and Glycine Formulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current stabilizers for immunoglobulin G (IgG) compositions are inefficient for both liquid and lyophilized forms, leading to instability issues such as aggregate formation, anaphylactic reactions, and unsatisfactory storage stability, and some are not suitable for individuals with renal failure or diabetes, with different stabilizers required for each form and potential Maillard reactions at acidic pH.
Innovation Solution
A pharmaceutically acceptable stabilizing formulation comprising a sugar alcohol, glycine, and a non-ionic detergent, such as mannitol and Tween®80, which provides joint stabilization for both liquid and lyophilized IgG compositions, reducing manufacturing costs and simplifying production while minimizing denaturation and oxidation risks.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If PEG 3000-6000 is added as a stabilizer to lyophilized IgG compositions, then storage stability is improved, but protein precipitation occurs during freezing leading to loss of IgG activity
Solution Approach 1:
The patent changes the chemical parameters of the stabilizer system by replacing PEG with a combination of sugars (sucrose, glucose, maltose) and amino acids (glycine, alanine, valine, leucine, isoleucine, phenylalanine, tyrosine, tryptophan, histidine, lysine, arginine, asparagine, glutamine, proline, threonine, serine, cysteine, methionine, aspartic acid, glutamic acid). This parameter change eliminates the harmful precipitation effect while maintaining storage stability through different stabilization mechanisms.
Solution Approach 2:
The patent employs a composite stabilizer system combining multiple sugars and amino acids working synergistically. This composite approach provides comprehensive protection during lyophilization and storage, preventing both aggregation and precipitation that occur with single-component stabilizers like PEG.
2Reliability
If different stabilizers are used for liquid and lyophilized IgG compositions, then stabilization efficiency is improved for each form, but manufacturing complexity and costs increase
Solution Approach 1:
The patent develops a universal stabilizer composition comprising specific sugars and amino acids that functions effectively for both liquid and lyophilized IgG formulations. This single composition can be used across different product forms, eliminating the need for separate stabilization strategies and simplifying manufacturing processes while maintaining high stabilization efficiency.
3Reliability
If acidic pH is used for liquid IgG compositions, then therapeutic efficacy is improved, but Maillard reactions occur leading to degradation of IgG and stabilizers
Solution Approach 1:
The patent applies preliminary protective action by incorporating amino acids (particularly lysine, arginine, histidine) and sugars that act as sacrificial agents, preferentially reacting with aldehydes before they can attack IgG molecules. This preliminary anti-action prevents Maillard degradation while allowing acidic pH to be maintained for therapeutic efficacy.
Solution Approach 2:
The stabilizer components, particularly amino acids and sugars, serve as intermediary substances that mediate between the acidic environment and the IgG molecules. These intermediaries buffer the harmful effects of acidic pH and prevent direct damaging interactions between acid-catalyzed reactive species and the protein structure.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation effectively stabilizes IgG compositions, reducing polymer and dimer formation, maintaining therapeutic efficiency, and ensuring stability over extended storage periods, including at acidic pH, without inducing adverse reactions, and is safe for patients with renal issues or diabetes.
Implementation Method 1
a sugar alcohol, glycine and a non-ionic detergent, in order to be suitable for the stabilization of immunoglobulins G compositions
Implementation Method 2
a non-ionic detergent, such as mannitol and Tween®80
Implementation Method 3
minimizing denaturation and oxidation risks
Implementation Method 4
Further physico-chemical deteriorations can also interfere during the storage of IgGs such as, inter alia, oxidation and hydrolysis
Data Source
AI summary
This invention is related to a stabilizing formulation for immunoglobulins G compositions comprising a sugar alcohol, glycine and a non-ionic detergent, which is suitable for the stabilization of immunoglobulins G compositions in liquid form and in lyophilized form. The invention also relates to an immunoglobulins G composition in liquid form or in lyophilized form comprising said stabilizing formulation.